Waltz Through OSS – RBA


New OSS-RBA

In furtherance to the Law No. 11 of 2020 on Job Creation, the enactment of Government Regulation No. 5 of 2021 brings changes to business licensing arrangements, known as OSS-RBA. It is an electronically integrated business licensing system that was launched on 9 August 2021 by the OSS. This risk-based business licensing system is divided into low risk, medium-low risk, medium-high risk, and high risk. Previously, business licenses were submitted through OSS version 1.1.

Ease of Doing Business in Indonesia

Despite the pandemic, the results of a World Bank shows that Indonesia is ranked 73 (out of 190 countries surveyed in the world). OSS RBA is intended to increase our EODB to remains competitive in the global market.

FDI considerations

Whether you are an experienced investor, investing overseas always comes with its own challenges. There are some factors to consider before investing into Indonesia.

Legal and immigration aspects

In relation to OSS-RBA, there are some changes in the Business Field Classification Number (KBLI).

Date/Time: Thursday, 16 September 2021 / 9:00AM – 11:30AM (GMT+7)

The webinar has ended

Who should attend

Chief Executive Officers, Chief Financial Officers, Chief Operational Officers, Chief Representatives, Managing Directors, Finance Directors, Financial Controllers, Investor Relations, Investors of all stripes, Business Owners who are planning to invest into Indonesia.

Agenda

Time Agenda
08:30 – 09:00 Registration
09:00 – 09:05 Welcoming Remarks by Nurmia Dwi Agustina, COO of Cekindo
09:05 – 09:30 Recent Trends of Foreign Direct Investment and Ease of Doing Business in Indonesia by Andi Maulana, Expert Staff for Investment Equity and Partnership, Ministry of Investment Indonesia (BKPM)
09:30 – 10:00 Road to OSS RBA and its navigation
10:00 – 10:40 FDI considerations in Indonesia by Pandu Biasramadhan, Consulting Manager of Cekindo
10:40 – 11:15 Legal Aspects of FDI in Indonesia by Tjhia Edy Tarlesno, Head of Legal of Cekindo
11:15 – 11:30 Q&A Session and Closing Remarks